Ads
related to: drugs, brain development
Search results
Study Identifies Genetic Variant as a Clear Cause of Alzheimer's—Does This Mean You Should Get...
Health via Yahoo News· 2 days agoNew research suggests that having two copies of a gene variant could be an underlying cause—not just...
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Reverse Stock Split
Digital Journal· 3 days agoPharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain< ...
CNS Pharmaceuticals Announces Reverse Stock Split
Digital Journal· 4 days agoThe Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin ...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 3 days agoMost famously, it causes phocomelia, a disorder that prevents the growth of arms and legs in utero,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day ago● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical
Pharma stock jumps 8% after company filed its first drug to treat blood volume loss with USFDA
Investing.com· 2 days agoPharma stock engaged in the business of manufacturing, sale, and research and development of generic...
Gene therapy offers huge potential for combating disease, doctors say
UPI· 7 days ago1 of 3 | Dr. Krystof Bankiewicz collaborates with his team in the lab at The Ohio State University...
FDA issues warning about baby formula that may be contaminated with dangerous bacteria
CNN via Yahoo News· 6 days agoThe US Food and Drug Administration issued a warning Friday about baby formula that may be...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoInnovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 SAN FRANCISCO, U.S. and
Too Much Internet Use Is Changing Teenage Brains, Study Finds
Forbes· 3 days agoExcessive use of the internet is reshaping teenage brains, according to a new study. Scans show that...